Robb Knie

Insider Reports History

Location
Campbell, CA
Signature
/s/ Hayley Springer as Attorney-In-Fact for Robb Knie
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robb Knie:

Company Role Class Num Shares Value Price $ Report Date Ownership
Hoth Therapeutics, Inc. CEO and President, Director Common Stock 547,387 $662,338 $1.21 28 Aug 2025 Direct
Hoth Therapeutics, Inc. CEO and President, Director Options 7,000 14 Jan 2025 Direct

Insider Reports Filed by Robb Knie

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HOTH Hoth Therapeutics, Inc. 27 Aug 2025 2 -$376,000 4 CEO and President, Director 28 Aug 2025, 18:48
HOTH Hoth Therapeutics, Inc. 14 Jan 2025 2 $0 4 CEO and President, Director 15 Jan 2025, 16:15
HOTH Hoth Therapeutics, Inc. 19 Aug 2024 1 $0 4 CEO and President, Director 21 Aug 2024, 16:15
HOTH Hoth Therapeutics, Inc. 16 Aug 2024 1 +$16,750 4 CEO and President, Director 19 Aug 2024, 08:00
HOTH Hoth Therapeutics, Inc. 05 Jan 2024 1 $0 4 CEO and President, Director 08 Jan 2024, 17:00
HOTH Hoth Therapeutics, Inc. 17 Jul 2023 1 $0 4 CEO and President, Director 18 Jul 2023, 16:15
HOTH Hoth Therapeutics, Inc. 19 Sep 2022 1 +$3,900 4 CEO and President, Director 20 Sep 2022, 08:00
HOTH Hoth Therapeutics, Inc. 16 Sep 2022 1 +$4,000 4 CEO and President, Director 19 Sep 2022, 11:05
HOTH Hoth Therapeutics, Inc. 16 Mar 2022 1 $0 4 CEO and President, Director 18 Mar 2022, 16:15